DE69627526D1 - Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung - Google Patents

Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung

Info

Publication number
DE69627526D1
DE69627526D1 DE69627526T DE69627526T DE69627526D1 DE 69627526 D1 DE69627526 D1 DE 69627526D1 DE 69627526 T DE69627526 T DE 69627526T DE 69627526 T DE69627526 T DE 69627526T DE 69627526 D1 DE69627526 D1 DE 69627526D1
Authority
DE
Germany
Prior art keywords
compositions
methods
cat
production
pox virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69627526T
Other languages
English (en)
Other versions
DE69627526T2 (de
Inventor
Enzo Paoletti
Russell Gettig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virogenetics Corp
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Application granted granted Critical
Publication of DE69627526D1 publication Critical patent/DE69627526D1/de
Publication of DE69627526T2 publication Critical patent/DE69627526T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69627526T 1995-12-01 1996-12-02 Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung Expired - Lifetime DE69627526T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US566398 1995-12-01
US08/566,398 US5858373A (en) 1995-12-01 1995-12-01 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
PCT/US1996/019274 WO1997020054A1 (en) 1995-12-01 1996-12-02 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them

Publications (2)

Publication Number Publication Date
DE69627526D1 true DE69627526D1 (de) 2003-05-22
DE69627526T2 DE69627526T2 (de) 2004-04-01

Family

ID=24262725

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627526T Expired - Lifetime DE69627526T2 (de) 1995-12-01 1996-12-02 Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung

Country Status (10)

Country Link
US (1) US5858373A (de)
EP (1) EP0868522B1 (de)
JP (2) JP2000501930A (de)
AT (1) ATE237691T1 (de)
AU (1) AU724172B2 (de)
CA (1) CA2237807C (de)
DE (1) DE69627526T2 (de)
ES (1) ES2210401T3 (de)
PT (1) PT868522E (de)
WO (1) WO1997020054A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505941A (en) * 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US5942997A (en) * 1997-08-29 1999-08-24 Trw Inc. Correlated superconductor single flux quantum analog-to-digital converter
FR2796397B1 (fr) * 1999-07-16 2006-09-01 Merial Sas Genes de calicivirus felin et vaccins notamment vaccins recombines
FR2796396A1 (fr) * 1999-07-16 2001-01-19 Merial Sas Gene de calicivirus felin et vaccin recombine les incorporant
US6541458B1 (en) * 1999-07-16 2003-04-01 Merial Feline calicivirus genes and vaccines in particular recombinant vaccines
JP4242607B2 (ja) * 2002-07-04 2009-03-25 学校法人北里研究所 ネコ伝染性腹膜炎ワクチン
EP1668112A4 (de) 2003-06-20 2009-04-29 Protein Sciences Corp Sars-immunogene exprimierende vektoren, solche vektoren oder expressionsprodukte davon enthaltende zusammensetzungen, verfahren und tests zur herstellung und verwendung
EP1680177B1 (de) * 2003-09-25 2017-04-12 NuVasive, Inc. Chirurgisches zugangssystem
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
EP2147105B1 (de) 2007-05-02 2013-04-24 Merial Limited Dna-plasmide mit verbesserter expression und stabilität
JP5263729B2 (ja) * 2007-12-21 2013-08-14 学校法人日本医科大学 ネコ伝染性腹膜炎ウイルス（ｆｉｐｖ）の予防及び治療剤
GB2460694A (en) * 2008-06-06 2009-12-09 Secr Defence Attenuated poxviruses
CN102791886B (zh) 2010-01-18 2015-04-08 乌得勒支大学控股有限公司 区分fecv和fipv的工具和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4769330A (en) * 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
JPS63123385A (ja) * 1986-09-05 1988-05-27 デュファル・インテルナチオナル・レセールフ・ベー・ヴェー 新規抗原的活性蛋白質およびぺプチド、並びにネコ科感染性腹膜炎ウイルスワクチン
DE10399031I1 (de) * 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
HUT54733A (en) * 1989-07-12 1991-03-28 Duphar Int Res Process for producing new, antigenically active proteins and peptides, as well as feline infectious peritonitis virus (fipv) vaccines
US5997878A (en) * 1991-03-07 1999-12-07 Connaught Laboratories Recombinant poxvirus-cytomegalovirus, compositions and uses
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease

Also Published As

Publication number Publication date
PT868522E (pt) 2003-08-29
WO1997020054A1 (en) 1997-06-05
EP0868522A4 (de) 1999-09-15
AU724172B2 (en) 2000-09-14
DE69627526T2 (de) 2004-04-01
US5858373A (en) 1999-01-12
EP0868522B1 (de) 2003-04-16
CA2237807C (en) 2003-10-07
CA2237807A1 (en) 1997-06-05
AU1278097A (en) 1997-06-19
JP2007105040A (ja) 2007-04-26
EP0868522A1 (de) 1998-10-07
ATE237691T1 (de) 2003-05-15
ES2210401T3 (es) 2004-07-01
JP2000501930A (ja) 2000-02-22

Similar Documents

Publication Publication Date Title
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
ATE386106T1 (de) Rekombinante poxvirus-cytomegalovirus zusammensetzungen und ihre verwendung
DE69627526D1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
ATE492289T1 (de) Herstellung von menschlichen papillomavirus hbv- 11 kapsidprotein l1 und virus-ähnliche partikeln
ATE252640T1 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
ATE91630T1 (de) Pharmazeutische zusammensetzung zur verhuetung oder heilung von durch den papillomavirus induzierten tumoren.
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
HUP9801334A2 (hu) A 18-as típusú humán papillomavírust kódoló DNS
DE59712852D1 (de) Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen
DK0831899T3 (da) Rekombinant koppevirus-calicivirus-præparater og anvendelser
ATE425187T1 (de) Materialien und methoden zur behandlung von hepatitis c
CA2210294A1 (en) Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
DE69028658D1 (de) Proteine, Vakzine und Nucleinsäuren
ATE324433T1 (de) Methoden zur herstellung rekombinanter bakterien, die eukaryontische gene beinhalten
ATE65543T1 (de) Dna-sequenzen des ebv-genoms, rekombinante dnamolek¨le, verfahren zur herstellung von ebvverwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
DE69635989D1 (de) Diagnostischer test für von pferdearthritisvirus verursachte krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition